Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 824, pseudogene (RNU6-824P) is a genomic sequence similar to the highly conserved U6 small nuclear RNA gene but contains mutations or structural changes that render it non-functional. U6 snRNA itself is a critical RNA component of the spliceosomal machinery in eukaryotes, essential for pre-mRNA splicing[1][3]. However, "pseudogene" variants such as RNU6-824P do not participate in splicing, gene regulation, or protein interactions and have no established physiological or pathological role[5]. U6 snRNA-derived pseudogenes are numerous in the human genome and result from gene duplication and subsequent loss of function. While some pseudogenes may theoretically regulate gene expression or serve as evolutionary vestiges, there is no evidence for a molecular or therapeutic role for RNU6-824P[3][5]. - If you are seeking information about a functional target, investigate U6 small nuclear RNA (U6 snRNA), not its pseudogenes[1][3]. - For drug and clinical research applications, RNU6-824P is not a relevant target.
None (no mechanism; not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 824, pseudogene (RNU6-824P).